Anika Therapeutics, Inc. ANIK
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.31M | -5.06M | 292.00K | -2.33M | -3.97M |
| Total Depreciation and Amortization | 1.51M | 1.41M | 1.32M | 1.40M | 1.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.69M | 7.99M | 4.16M | 3.39M | 6.35M |
| Change in Net Operating Assets | -9.19M | -9.19M | -1.13M | 4.41M | -3.83M |
| Cash from Operations | -684.00K | -4.85M | 4.64M | 6.87M | -189.00K |
| Capital Expenditure | -1.45M | -1.43M | -648.00K | -1.89M | -1.47M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 0.00 | 4.50M |
| Other Investing Activities | 169.00K | 192.00K | 846.00K | 155.00K | -3.57M |
| Cash from Investing | -1.28M | -1.24M | 198.00K | -1.73M | -539.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 210.00K | -- | 239.00K | 0.00 | 261.00K |
| Repurchase of Common Stock | -911.00K | -10.35M | -5.52M | -13.00K | -82.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -701.00K | -10.35M | -5.28M | -13.00K | 179.00K |
| Foreign Exchange rate Adjustments | 57.00K | -29.00K | -65.00K | -302.00K | 345.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.61M | -16.46M | -509.00K | 4.82M | -204.00K |